Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1985 1
1989 2
1990 2
1991 1
1993 2
1994 2
1995 7
1996 5
1997 5
1998 6
1999 11
2000 9
2001 9
2002 5
2003 6
2004 3
2005 7
2006 15
2007 6
2008 11
2009 8
2010 10
2011 13
2012 11
2013 5
2014 11
2015 3
2016 9
2017 10
2018 5
2019 6
2020 9
2021 11
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Results by year
Filters applied: . Clear all
Page 1
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.
Moreau P, Mateos MV, Berenson JR, Weisel K, Lazzaro A, Song K, Dimopoulos MA, Huang M, Zahlten-Kumeli A, Stewart AK. Moreau P, et al. Among authors: berenson jr. Lancet Oncol. 2018 Jul;19(7):953-964. doi: 10.1016/S1470-2045(18)30354-1. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29866475 Clinical Trial.
Carfilzomib in multiple myeloma.
Andreu-Vieyra C, Berenson JR. Andreu-Vieyra C, et al. Among authors: berenson jr. Expert Opin Biol Ther. 2014 Nov;14(11):1685-99. doi: 10.1517/14712598.2014.953050. Epub 2014 Aug 29. Expert Opin Biol Ther. 2014. PMID: 25170966 Review.
Myeloma bone disease.
Berenson JR. Berenson JR. Best Pract Res Clin Haematol. 2005;18(4):653-72. doi: 10.1016/j.beha.2005.03.001. Best Pract Res Clin Haematol. 2005. PMID: 16026743 Review.
Pathophysiology of bone metastases.
Berenson JR, Rajdev L, Broder M. Berenson JR, et al. Cancer Biol Ther. 2006 Sep;5(9):1078-81. doi: 10.4161/cbt.5.9.3306. Epub 2006 Sep 20. Cancer Biol Ther. 2006. PMID: 17012831 Review.
The role of JAK inhibitors in multiple myeloma.
Ghermezi M, Spektor TM, Berenson JR. Ghermezi M, et al. Among authors: berenson jr. Clin Adv Hematol Oncol. 2019 Sep;17(9):500-505. Clin Adv Hematol Oncol. 2019. PMID: 31549971 Review.
Monitoring multiple myeloma.
Udd KA, Spektor TM, Berenson JR. Udd KA, et al. Among authors: berenson jr. Clin Adv Hematol Oncol. 2017 Dec;15(12):951-961. Clin Adv Hematol Oncol. 2017. PMID: 29315287
Bisphosphonates in multiple myeloma.
Berenson JR. Berenson JR. Cancer. 1997 Oct 15;80(8 Suppl):1661-7. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1661::aid-cncr16>3.3.co;2-t. Cancer. 1997. PMID: 9362433 Review.
Bone complications in multiple myeloma.
Berenson JR, Rajdev L, Broder M. Berenson JR, et al. Cancer Biol Ther. 2006 Sep;5(9):1082-5. doi: 10.4161/cbt.5.9.3307. Epub 2006 Sep 20. Cancer Biol Ther. 2006. PMID: 16969119 Review.
Treatment for myeloma bone disease.
Yeh HS, Berenson JR. Yeh HS, et al. Among authors: berenson jr. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6279s-6284s. doi: 10.1158/1078-0432.CCR-06-0681. Clin Cancer Res. 2006. PMID: 17062714 Free article. Review.
Myeloma bone disease and treatment options.
Yeh HS, Berenson JR. Yeh HS, et al. Among authors: berenson jr. Eur J Cancer. 2006 Jul;42(11):1554-63. doi: 10.1016/j.ejca.2005.11.035. Epub 2006 Jun 22. Eur J Cancer. 2006. PMID: 16797971 Review.
205 results